Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium Kit
Product Images NDC 0781-4075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium (NDC 0781-4075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

50419 0407 01 Splimage30 42192129

50419 0407 01 Splimage30 42192129
FDA Label Image

50419 0407 01 Splimage30 44192279

50419 0407 01 Splimage30 44192279
FDA Label Image

52a786c4 4ace 46f0 Bda2 2de721b1bb47 00

52a786c4 4ace 46f0 Bda2 2de721b1bb47 00
This text presents a list of studies focused on the risk of breast cancer associated with combined oral contraceptives (COC) use. The studies analyzed the risk between ever COC use and never COC use, as well as current COC use and never-use. The text includes some statistical information such as effect estimates, OR, RR, and HR.*
FDA Label Image

Fig 1 (Image 01)

Fig 1 (Image 01)
FDA Label Image

Fig 2 (Image 02)

Fig 2 (Image 02)
This is a chart displaying the ranges of blood clot occurrences among non-pregnant women, non-COC users, COC users, and postpartum women. The numbers are given out of 10,000 Women Years (WY). There is also a note stating that the pregnancy data is based on actual duration of pregnancy and that the rate of blood clot occurrence is between 7 and 27 per 10,000 WY.*
FDA Label Image

Structures (Image 03)

Structures (Image 03)
FDA Label Image

Fig 3 (Image 04)

Fig 3 (Image 04)
FDA Label Image

Fig 4 (Image 05)

Fig 4 (Image 05)
FDA Label Image

Fig 5 (Image 06)

Fig 5 (Image 06)
FDA Label Image

Fig 6 (Image 07)

Fig 6 (Image 07)
FDA Label Image

Birth Control Chart (Image 08)

Birth Control Chart (Image 08)
This text describes different methods of birth control and their effectiveness rates. The text displays effectiveness rates in terms of pregnancy per 100 women. The text lists methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The most effective methods listed are sterilization and intrauterine devices, while the least effective method listed is no birth control.*
FDA Label Image

Blister (Image 09)

Blister (Image 09)
FDA Label Image

Vte Chart (Image 10)

Vte Chart (Image 10)
This text provides ranges for non-pregnant women who are either non-COC users or cocusers, as well as ranges for pregnant and postpartum women in terms of the number of women with a blood clot out of 10,000 women years. The pregnancy data is based on actual duration of pregnancy in reference studies, and the rate is assumed to be 7 to 27 per 10,000 WY if pregnancy duration is nine months.*
FDA Label Image

Carton 3s (Image 11)

Carton 3s (Image 11)
Drospirenone/Ethinyl Estradiol/Levomefolate Calcium Tablets and Levomefolate Calcium Tablets with NDC 0781-4075.15 is a product intended for birth control purposes. It comes in 3mg/0.02mg/0.451 mg and 0.451 mg strength and is manufactured by Sandoz. The product is sold in 3 units of 28 oral tablets. The text mentions some symbols, but no further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.